Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 7879691, 6 pages
https://doi.org/10.1155/2017/7879691
Research Article

Efficacy of One-Year Treatment with Aflibercept for Diabetic Macular Edema with Practical Protocol

Department of Ophthalmology and Visual Science, Chiba University, Graduate School of Medicine, Chiba, Japan

Correspondence should be addressed to Toshiyuki Oshitari; moc.loa@iirat

Received 13 July 2017; Accepted 12 November 2017; Published 4 December 2017

Academic Editor: Atsushi Mizota

Copyright © 2017 Tomomi Kaiho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. O'Doherty, I. Dooley, and M. Hickey-Dwyer, “Interventions for diabetic macular oedema: a systematic review of the literature,” British Journal of Ophthalmology, vol. 92, no. 12, pp. 1581–1590, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. W. Yau, S. L. Rogers, R. Kawasaki et al., “Global prevalence and major risk factors of diabetic retinopathy,” Diabetes Care, vol. 35, no. 3, pp. 556–564, 2012. View at Publisher · View at Google Scholar
  3. P. Mitchell, F. Bandello, U. Schmidt-Erfurth et al., “The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema,” Ophthalmology, vol. 118, no. 4, pp. 615–625, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. Diabetic Retinopathy Clinical Research Network, M. J. Elman, and H. Qin, “Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results,” Ophthalmology, vol. 119, pp. 2312–2318, 2012. View at Publisher · View at Google Scholar
  5. M. B. Sultan, D. Zhou, J. Loftus, T. Dombi, and K. S. Ice, “A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema,” Ophthalmology, vol. 118, no. 6, pp. 1107–1118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. D. V. Do, Q. D. Nguyen, D. Boyer et al., “One-year outcomes of the da VINCI study of VEGF trap-eye in eyes with diabetic macular edema,” Ophthalmology, vol. 119, no. 8, pp. 1658–1665, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Ishibashi, X. Li, A. Koh et al., “The REVEAL Study: ranibizumab monotherapy or combined with laser versus laser monotherapy in asian patients with diabetic macular edema,” Ophthalmology, vol. 122, no. 7, pp. 1402–1415, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. D. M. Brown, U. Schmidt-Erfurth, and D. V. Do, “Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID Studies,” Ophthalmology, vol. 122, no. 10, pp. 2044–2052, 2015. View at Publisher · View at Google Scholar
  9. M. J. Elman, A. Ayala, N. M. Bressler et al., “Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results,” Ophthalmology, vol. 122, no. 2, pp. 375–381, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. U. Schmidt-Erfurth, G. E. Lang, F. G. Holz et al., “Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study,” Ophthalmology, vol. 121, no. 5, pp. 1045–1053, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. E. L. Ross, D. W. Hutton, J. D. Stein, N. M. Bressler, L. M. Jampol, and A. R. Glassman, “Cost-effectiveness of aflibercept, bevacizumab, and ranibizumab for diabetic macular edema treatment analysis from the diabetic retinopathy clinical research network comparative effectiveness trial,” JAMA Ophthalmology, vol. 134, no. 8, pp. 888–896, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Shimizu, T. Oshitari, T. Tatsumi et al., “Comparison of efficacy of intravitreal aflibercept and ranibizumab in eyes with diabetic macular edema,” BioMed Research International, vol. 2017, Article ID 1747108, 7 pages, 2017. View at Google Scholar
  13. K. H. Seo, S.-Y. Yu, M. Kim, and H. W. Kwak, “Visual and morphologic outcomes of intravitreal ranibizumab for diabetic macular edema based on optical coherence tomography patterns,” Retina, vol. 36, no. 3, pp. 588–595, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Giocanti-Aurégan, L. Hrarat, L. M. Qu et al., “Functional and anatomical outcomes in patients with serous retinal detachment in diabetic macular edema treated with ranibizumab,” Investigative Ophthalmology & Visual Science, vol. 58, no. 2, pp. 797–800, 2017. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Mori, K. Suzuma, A. Uji et al., “Restoration of foveal photoreceptors after intravitreal ranibizumab injections for diabetic macular edema,” Scientific Reports, vol. 6, Article ID 39161, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. H. J. Shin, S. H. Lee, H. Chung, and H. C. Kim, “Association between photoreceptor integrity and visual outcome in diabetic macular edema,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 250, no. 1, pp. 61–70, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Forooghian, P. F. Stetson, S. A. Meyer et al., “Relationship between photoreceptor outer segment length and visual acuity in diabetic macular edema,” Retina, vol. 30, no. 1, pp. 63–70, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D.-H. Lee, J. T. Kim, D.-W. Jung, S. G. Joe, and Y. H. Yoon, “The relationship between foveal ischemia and spectral-domain optical coherence tomography findings in ischemic diabetic macular edema,” Investigative Ophthalmology & Visual Science, vol. 54, no. 2, pp. 1080–1085, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Shiono, J. Kogo, G. Klose et al., “Photoreceptor outer segment length: a prognostic factor for idiopathic epiretinal membrane surgery,” Ophthalmology, vol. 120, no. 4, pp. 788–794, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Kogo, A. Shiono, H. Sasaki et al., “Foveal microstructure analysis in eyes with diabetic macular edema treated with vitrectomy,” Advances in Therapy, vol. 34, no. 9, pp. 2139–2149, 2017. View at Publisher · View at Google Scholar
  21. N. V. Patrao, S. Antao, C. Egan et al., “Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service Setting,” American Journal of Ophthalmology, vol. 172, pp. 51–57, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Brynskov, C. S. Laugesen, and T. L. Sørensen, “Intravitreal ranibizumab for diabetic macular oedema: 1-year experiences in a clinical setting,” Acta Ophthalmologica, vol. 91, no. 3, pp. e243–e244, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Hrarat, F. Fajnkuchen, M. Boubaya et al., “Outcomes after a 1-Year Treatment with Ranibizumab for Diabetic Macular Edema in a Clinical Setting,” Ophthalmologica, vol. 236, no. 4, pp. 207–214, 2017. View at Publisher · View at Google Scholar · View at Scopus
  24. K. J. Blinder, P. U. Dugel, S. Chen et al., “Anti-VEGF treatment of diabetic macular edema in clinical practice: Effectiveness and patterns of use (ECHO study report 1),” Clinical Ophthalmology, vol. 11, pp. 393–401, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. U. Menchini, F. Bandello, V. De Angelis et al., “Ranibizumab for visual impairment due to diabetic macular edema: real-world evidence in the Italian population (pride study),” Journal of Ophthalmology, vol. 2015, Article ID 324841, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Yuodelis and A. Hendrickson, “A qualitative and quantitative analysis of the human fovea during development,” Vision Research, vol. 26, no. 6, pp. 847–855, 1986. View at Publisher · View at Google Scholar · View at Scopus
  27. C. A. Curcio, K. R. Sloan, R. E. Kalina, and A. E. Hendrickson, “Human photoreceptor topography,” Journal of Comparative Neurology, vol. 292, no. 4, pp. 497–523, 1990. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Fujihara-Mino, Y. Mitamura, N. Inomoto, H. Sano, K. Akaiwa, and K. Semba, “Optical coherence tomography parameters predictive of visual outcome after anti-VEGF therapy for retinal vein occlusion,” Clinical Ophthalmology, vol. 10, pp. 1305–1313, 2016. View at Publisher · View at Google Scholar · View at Scopus